Astria Therapeutics's market cap is currently $394.48M. The company's EPS TTM is $-2.093; its P/E ratio is ―; Astria Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ -26.00K
Operating Income	$ -83.03M	$ -53.50M	$ -194.98M	$ -37.44M	$ -27.09M
EBITDA	$ -83.03M	$ -53.50M	$ -194.98M	$ -37.44M	$ -26.27M
Net Income	$ -72.89M	$ -50.16M	$ -30.17M	$ -37.06M	$ -26.24M
Balance Sheet
Cash & Short-Term Investments	$ 246.53M	$ 226.44M	$ 125.51M	$ 44.93M	$ 36.24M
Total Assets	$ 254.67M	$ 230.63M	$ 127.51M	$ 47.46M	$ 41.78M
Total Debt	$ 329.00K	$ 939.00K	$ 365.00K	$ 1.05M	$ 2.25M
Net Debt	$ -175.20M	$ -19.59M	$ -86.14M	$ -23.88M	$ -7.65M
Total Liabilities	$ 11.55M	$ 9.42M	$ 5.20M	$ 6.79M	$ 6.06M
Stockholders' Equity	$ 243.12M	$ 221.22M	$ 122.31M	$ 40.67M	$ 35.72M
Cash Flow
Free Cash Flow	$ -68.47M	$ -43.62M	$ -30.17M	$ -32.52M	$ -26.58M
Operating Cash Flow	$ -68.44M	$ -43.53M	$ -30.15M	$ -32.48M	$ -26.57M
Investing Cash Flow	$ 135.05M	$ -167.13M	$ -12.55M	$ 6.30M	$ -4.08M
Financing Cash Flow	$ 88.40M	$ 144.72M	$ 104.28M	$ 40.86M	$ 25.62M

Currency in USD

Astria Therapeutics Earnings and Revenue History

Income Statement >

Astria Therapeutics Debt to Assets

Balance Sheet >

Astria Therapeutics Cash Flow

Cash Flow >

Astria Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing